Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Herrmann

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
JAMA Neurology|June 26, 2013
High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trialRichard A Lewis, Michael P McDermott, David N Herrmann, et al.
Journal of the Peripheral Nervous System : JPNS|August 27, 2020
Reliability of the Charcot-Marie-Tooth functional outcome measurePaula Bray, Kayla M D Cornett, Timothy Estilow, et al.
Neurology|January 18, 2024
Multicenter Validation of the Charcot-Marie-Tooth Functional Outcome MeasureMelissa R Mandarakas, Katy J Eichinger, Paula Bray, et al.
Pain Reports|October 30, 2023
A randomized, double-blind, placebo-controlled study of histone deacetylase type 6 inhibition for the treatment of painful diabetic peripheral neuropathyDavid Michelson, William W Chin, Robert H Dworkin, et al.
Foot & Ankle International|June 2, 2020
A Consensus Statement on the Surgical Treatment of Charcot-Marie-Tooth DiseaseGlenn B Pfeffer, Tyler Gonzalez, James Brodsky, et al.
Journal of the National Cancer Institute|March 14, 2014
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomicsLois B Travis, Sophie D Fossa, Howard D Sesso, et al.
Neurology|August 4, 2017
Cross-sectional analysis of a large cohort with X-linked Charcot-Marie-Tooth disease (CMTX1)Francis B Panosyan, Matilde Laura, Alexander M Rossor, et al.
Brain : a Journal of Neurology|March 22, 2023
Neuropathy due to bi-allelic SH3TC2 variants: genotype-phenotype correlation and natural historyTyler Rehbein, Tong Tong Wu, Simona Treidler, et al.
Neurology|July 20, 2019
Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic reviewJennifer S Gewandter, Christopher H Gibbons, Marta Campagnolo, et al.
Pharmacology Research & Perspectives|July 5, 2024
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areataSamira Anderson, Guido Cavaletti, Linda J Hood, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
JAMA Neurology|June 26, 2013
High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trialRichard A Lewis, Michael P McDermott, David N Herrmann, et al.
Journal of the Peripheral Nervous System : JPNS|August 27, 2020
Reliability of the Charcot-Marie-Tooth functional outcome measurePaula Bray, Kayla M D Cornett, Timothy Estilow, et al.
Neurology|January 18, 2024
Multicenter Validation of the Charcot-Marie-Tooth Functional Outcome MeasureMelissa R Mandarakas, Katy J Eichinger, Paula Bray, et al.
Pain Reports|October 30, 2023
A randomized, double-blind, placebo-controlled study of histone deacetylase type 6 inhibition for the treatment of painful diabetic peripheral neuropathyDavid Michelson, William W Chin, Robert H Dworkin, et al.
Foot & Ankle International|June 2, 2020
A Consensus Statement on the Surgical Treatment of Charcot-Marie-Tooth DiseaseGlenn B Pfeffer, Tyler Gonzalez, James Brodsky, et al.
Journal of the National Cancer Institute|March 14, 2014
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomicsLois B Travis, Sophie D Fossa, Howard D Sesso, et al.
Neurology|August 4, 2017
Cross-sectional analysis of a large cohort with X-linked Charcot-Marie-Tooth disease (CMTX1)Francis B Panosyan, Matilde Laura, Alexander M Rossor, et al.
Brain : a Journal of Neurology|March 22, 2023
Neuropathy due to bi-allelic SH3TC2 variants: genotype-phenotype correlation and natural historyTyler Rehbein, Tong Tong Wu, Simona Treidler, et al.
Neurology|July 20, 2019
Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic reviewJennifer S Gewandter, Christopher H Gibbons, Marta Campagnolo, et al.
Pharmacology Research & Perspectives|July 5, 2024
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areataSamira Anderson, Guido Cavaletti, Linda J Hood, et al.
Pageof 13